Eptifibatide CAS:188627-80-7

Eptifibatide (Integrilin, Millennium pharmaceuticals, Etiam co-promovetur ab Schering, aratrum / Essex), An antiplatet medicamento de glycoprotein iib / IIia inhibitor genus.[1] Eptifibatide est cyclic HEPTAPEPTIDE ex dapibus in venenum in Southertern Pygmy Rattlesnake (Sistrurus Miliarius Barbouri). Hoc pertinet ad genus de sic dicta Arginin-glycin-aspartat, mimetics et reversibly ligat ad platelets. Eptifibatide habet brevi dimidium-vitae. In medicamento est tertia inhibitor GPIIB / IIia quae inventa lata acceptatio post specifica antibody abciximab et non-peptide Tirofiban ingressus global foro.

Eptifibatide adhibetur ad redigendum periculum acuti cardiac ischemic certe (mortem et / vel myocardial infarction) In aegris cum instabiles angina vel non-Sancti-segmentum-elevatio (E.g., non-Q, undam) myocardial infarction (i.e., Non-Sancti-Segmentum elevatio acutus coronarius syndromes) et in aegris qui sunt accipere non surgery (optimatium) Medical curatio et qui permitti percutaneous coronarius interventu (PCI). Et medicamento plerumque applicantur cum Aspirin aut clopidogrel et (Minimum M. pondus seu udicious) Heparin. Insuper, Solito adminicula curatio constans applications de nitrates, beta-blockers, Opioid analgesics et / vel benzodiazepines debet adhiberi ut indicavit. Angiographic Aestimatio et Alius intensive Diagnostic ratio potest considerari a prima linea ante initium Lorem cum EPTIFIBABATIDE. Et medicamento debet esse solum in hospitalized aegris et propter gravi gradu de aegris’ morbum et propter possibile latere effectis Eptifibatide.